Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...
Affera momentum continues as Medtronic announces CE Mark in Europe & US IDE first cases for Sphere-360 PFA catheter to treat paroxysmal atrial fibrillation: Galway, Ireland Tuesda ...
ASX healthcare rises for week ending January 23, 2026 as Morgans' Scott Power says focus shifts to quarterly reporting season ...
Medtronic plc , a global leader in healthcare technology, today announced two major milestones for the Afferatm Sphere-360tm catheter, a first-of-its-kind, all-in-one mapping and single-shot pulsed ...
Millions of Americans experience an irregular heartbeat, which can be unsettling and scary. When irregular heartbeats happen — and they happen a lot — electrophysiologists have sophisticated solutions ...
The system enters a field that sees PFA catheters largely displacing thermal modalities for catheter ablation of AF.
The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...
A new trial suggests Apple Watch could make a meaningful difference in what happens after atrial fibrillation ablation, not ...
Medtronic announced two new milestones for its Affera Sphere-360 catheter for pulsed field ablation (PFA) procedures.
Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results